In 2006, a research team from the University of California, San Diego (UCSD), and Yale University discovered that hookworm infection could be effectively treated with Cry5B, a protein produced by Bacillus thuringiensis (Bt). Bt, in spray form and as part of genetically enhanced crops, has so far successfully been used in agriculture to protect crops from pests.
The UCSD-Yale team gave the Cry5B Bt protein orally to lab hamsters and found that it killed or damaged larval and adult parasites as well as parasite eggs. It proved as potent as the Mebendazole drug, which is commonly used to treat hookworm infections. The researchers also experimented with other crystal proteins Cry6A, Cry14A and others related to them and found that only a select few could target the parasites effectively.
According to the researchers, the crystal proteins cannot bind with human or mammalian cells and therefore are safe for humans and mammals.
Using these crystal proteins in tandem with drugs like Mebendazole could lead to more effective treatments against human intestinal parasites. Finding newer, safer treatments is necessary as parasites have a tendency of becoming resistant to existing ones.